2[1]George A.The microinflammatory state in uremia:causes and potential consequences[J].J Am Soc Nephrol,2001,12(7):1549-1557.
3[2]Dupuy AM,Terrier N,Senecal L,et al.Is C-reactive protein a marker of inflammation[J]? Nephrologie,2003,24(7):337-341.
4[3]Roberts WL,Sedrick R,Moulton L,et al.Evaluation of four automated high-sensitivity C-reactive protein methods:implications for clinical and epidemiological applications[J].Clin Chem,2000,46(4):461-468.
5[6]Zebrack JS,Anderson JL,Beddhu S,et al.Do associations with C-reactive protein and extent of coronary artery disease account for the increased cardiovascular risk of renal insufficiency[J]? J Am Coll Cardiol,2003,42(1):57-63.
6[8]Memoli B,Minutolo R,Bisesti V,et al.Changes of serum albumin and C-reactive protein are related to changes of interleukin-6 release by peripheral blood mononuclear cells in hemodialysis patients treated with different membranes[J].Am J Kidney Dis,2002,39(2):266-273.
7[9]Schiffl H,Lang SM,Stratakis D,et al.Effects of ultrapure dialysis fluid on nutritional status and inflammatory parameters[J].Nephrol Dial Transplant,2001,16(9):1863-1869.
8[10]Foley RN,Guo H,Snyder JJ,et al.Septicemia in the United States dialysis population,1991 to 1999[J].J Am Soc Nephrol,2004,15(4):1038-1045.
9[11]Suliman ME,Stenvinkel P,Qureshi AR,et al.Hyperhomocysteinemia in relation to plasma free amino acids,biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy[J].Am J Kidney Dis,2004,44(3):455-465.
10[12]Busch M,Franke S,Muller A,et al.Potential cardiovascular risk factors in chronic kidney disease:AGEs,total homocysteine and metabolites,and the C-reactive protein[J].Kidney Int,2004,66(1):338-347.
